BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 32299208)

  • 1. Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic.
    Mandal H
    Turk J Med Sci; 2020 Apr; 50(SI-1):485-488. PubMed ID: 32299208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern.
    Song P; Karako T
    Biosci Trends; 2020 Mar; 14(1):1-2. PubMed ID: 32092748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [It's world war at CoViD-19. The first battle on the front of the viral invasion against the exitus for interstitial pneumonia was decisive.].
    Basta G; Del Turco S; Caselli C; Melani L; Vianello A
    Recenti Prog Med; 2020 Apr; 111(4):238-252. PubMed ID: 32319446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community.
    Rotondi M; Nieto-Diaz M; Magri F; Oliviero A
    Eur J Intern Med; 2020 Jul; 77():152. PubMed ID: 32487369
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives.
    Zamora-Ledezma C; C DFC; Medina E; Sinche F; Santiago Vispo N; Dahoumane SA; Alexis F
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33050601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in Turkey: Lessons Learned.
    Cakir B
    J Epidemiol Glob Health; 2020 Jun; 10(2):115-117. PubMed ID: 32538025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full Throttle: COVID-19 Open Science to Build Planetary Public Goods.
    Von Schomberg R; Özdemir V
    OMICS; 2020 Sep; 24(9):509-511. PubMed ID: 32628565
    [No Abstract]   [Full Text] [Related]  

  • 8. Timely access to trial data in the context of a pandemic: the time is now.
    Li R; Wood J; Baskaran A; Neumann S; Graham E; Levenstein M; Sim I
    BMJ Open; 2020 Oct; 10(10):e039326. PubMed ID: 33122319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: endgames.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 May; 20(5):511. PubMed ID: 32311325
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-reported outcomes: central to the management of COVID-19.
    Aiyegbusi OL; Calvert MJ
    Lancet; 2020 Aug; 396(10250):531. PubMed ID: 32791038
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 16. Access to Health and Medical Research: Lessons from the COVID-19 Pandemic.
    Aboyeji FO
    J Law Med; 2020 Aug; 27(4):901-913. PubMed ID: 32880408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A timely update of global COVID-19 vaccine development.
    Klavinskis LS; Liu MA; Lu S
    Emerg Microbes Infect; 2020 Dec; 9(1):2379-2380. PubMed ID: 33059515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can nanotechnology help in the fight against COVID-19?
    Palestino G; García-Silva I; González-Ortega O; Rosales-Mendoza S
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):849-864. PubMed ID: 32574081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.